Source: VETSTEM Marketing Department

From April 8 to 10, 2026, the 34th Moscow International Veterinary Congress (MVC 2026) will take place at the Skolkovo Innovation Center Technopark — one of the largest professional events in Russia’s veterinary industry. A pre-congress day is scheduled for April 7. VETSTEM LLC, a Skolkovo resident and manufacturer of VEZOTIL®, will take part in the congress.

MVC 2026 will bring together over 350 speakers, including international lecturers, and several thousand practicing veterinarians, researchers, and business representatives. The congress program includes scientific reports, practical master classes, lectures in anesthesiology, surgery, diagnostics, laboratory testing, and other areas. A specialized exhibition of veterinary pharmaceutical and equipment manufacturers will also be held as part of the event.

For VETSTEM LLC, participation in MVC 2026 is of special importance. The congress is held at the Skolkovo Technopark — the same innovation center where the company is a resident. This symbolically highlights the connection between innovative development and its implementation in clinical practice.

In 2025–2026, VETSTEM LLC accumulated a substantial scientific base for VEZOTIL®. The results of several clinical studies have been published, including a comparative study involving specialists from the Biocontrol center and O.V. Zakirova’s work on chronic pain control. The congress will provide a platform to present these data to the wider professional community.

As part of MVC 2026, prestigious professional awards will also be presented — the “Golden Scalpel” award, the “Silver Microscope,” the V.N. Mitin Medal, and the “Veterinary Cross” order. Detailed information about the congress program is available at vet-congress.ru. Current updates, special booth activities, and other VETSTEM LLC offerings at MVC 2026 are published in the Telegram channel @vetstemru and the company’s other social media channels.